Thomas J Polascik Selected Research

Therapeutics

12/2023	Intratumoural immunotherapy plus focal thermal ablation for localized prostate cancer.
12/2023	Primary Whole-gland Ablation for the Treatment of Clinically Localized Prostate Cancer: A Focal Therapy Society Best Practice Statement.
9/2023	"Quality: a parallel priority to quantity in prostate cancer focal therapy".
1/2023	Focal cryotherapy for prostate cancer: a contemporary literature review.
1/2023	A Comprehensive Assessment of the Utility of Transperineal Template Prostate Mapping Biopsy: A 13-year Experience.
1/2023	Patient-reported functional outcomes and oncological control after primary focal cryotherapy for clinically significant prostate cancer: A Phase II mandatory biopsy-monitored study.
1/2023	Focal Therapy for Prostate Cancer: Evolutionary Parallels to Breast Cancer Treatment. Letter.
1/2023	Is time to castration resistant prostate cancer a potential intermediate end-point for time to metastasis among men initiating androgen deprivation therapy for non-metastatic prostate cancer with rapid PSA doubling time (<9 months)?
1/2023	Oncological and Functional Outcomes for Men Undergoing Salvage Whole-gland Cryoablation for Radiation-resistant Prostate Cancer.
11/2022	Molecular Mechanisms of Castrate-Resistant Prostate Cancer.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Thomas J Polascik Research Topics

Disease

149	Prostatic Neoplasms (Prostate Cancer) 04/2024 - 07/2002
70	Neoplasms (Cancer) 01/2024 - 07/2002
12	Renal Cell Carcinoma (Grawitz Tumor) 03/2019 - 12/2006
11	Neoplasm Metastasis (Metastasis) 12/2023 - 07/2002
6	Kidney Neoplasms (Kidney Cancer) 11/2018 - 08/2008
5	Fistula 01/2021 - 05/2007
5	Carcinoma (Carcinomatosis) 01/2008 - 02/2002
4	Necrosis 03/2012 - 07/2002
3	Breast Neoplasms (Breast Cancer) 01/2023 - 09/2009
3	Urinary Incontinence 01/2023 - 01/2019
3	Disease Progression 01/2022 - 10/2018
3	Adenocarcinoma 01/2022 - 04/2012
3	Urinary Retention 06/2021 - 01/2019
3	Erectile Dysfunction 01/2021 - 08/2011
3	Margins of Excision 12/2012 - 11/2009
3	Pain (Aches) 08/2009 - 09/2008
2	Extranodal Extension 11/2014 - 11/2009
2	Hypoxia (Hypoxemia) 09/2010 - 08/2010
2	Carcinogenesis 05/2010 - 03/2009
2	Solitary Kidney 09/2008 - 12/2006
2	Hemorrhage 08/2008 - 04/2003
1	Stress Urinary Incontinence 01/2023
1	Prostatic Hyperplasia (Benign Prostatic Hyperplasia) 01/2021
1	Chronic Kidney Failure (Chronic Renal Failure) 01/2019
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 04/2012
1	Obesity 04/2012
1	Weight Loss (Weight Reduction) 10/2011

Drug/Important Bio-Agent (IBA)

33	Prostate-Specific Antigen (Semenogelase)IBA 01/2024 - 02/2002
7	Hormones (Hormone)IBA 01/2021 - 02/2002
6	Biomarkers (Surrogate Marker)IBA 01/2024 - 11/2005
6	AndrogensIBA 01/2023 - 07/2002
3	AntigensIBA 12/2023 - 09/2009
3	IceIBA 09/2021 - 04/2011
3	Zoledronic Acid (Zometa)FDA Link 09/2009 - 11/2005
2	Androgen Receptors (Androgen Receptor)IBA 01/2022 - 01/2021
2	Prostaglandins GIBA 12/2019 - 01/2018
2	CytokinesIBA 05/2014 - 10/2011
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 04/2013 - 10/2011
2	Cholecalciferol (Vitamin D3)FDA Link 03/2012 - 09/2010
2	pimonidazoleIBA 09/2010 - 08/2010
2	Diphosphonates (Bisphosphonates)IBA 09/2009 - 02/2008
2	CreatinineIBA 08/2009 - 12/2006
2	AntiemeticsIBA 08/2009 - 09/2008
2	Dietary Fats (Dietary Fat)IBA 12/2008 - 01/2008
1	Volatile Organic CompoundsIBA 01/2024
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2024
1	Dihydrotachysterol (AT 10)IBA 12/2023
1	Fluconazole (Zonal)FDA LinkGeneric 01/2023
1	Radium-223IBA 01/2022
1	Heat-Shock Proteins (Heat-Shock Protein)IBA 01/2022
1	Protein-Arginine N-Methyltransferases (Methyltransferase, Protein Arginine)IBA 01/2022
1	N-(2-naphthalene)sulfonyl-DL-tryptophan (A 91)IBA 06/2021
1	Docetaxel (Taxotere)FDA Link 01/2021
1	taxaneIBA 01/2021
1	abirateroneIBA 01/2021
1	cabazitaxel FDA Link 01/2021
1	RadiumIBA 01/2020
1	Prostaglandins AIBA 01/2020
1	2,2'- azino- di- (3- ethylbenzothiazoline)- 6- sulfonic acid (ABTS)IBA 08/2018
1	SolutionsIBA 11/2016
1	RNA (Ribonucleic Acid)IBA 05/2015
1	DNA (Deoxyribonucleic Acid)IBA 05/2015
1	2,3-bis(3'-hydroxybenzyl)butane-1,4-diol (enterodiol)IBA 04/2013
1	NF-kappa B (NF-kB)IBA 04/2013
1	2,3-bis(3'-hydroxybenzyl)butyrolactone (enterolactone)IBA 04/2013
1	LignansIBA 04/2013
1	Testosterone (Sustanon)FDA Link 04/2012
1	Indium-111IBA 03/2012
1	alpha-Linolenic Acid (Linolenic Acid)IBA 01/2012
1	Calcitriol (Calcijex)FDA LinkGeneric 09/2010
1	Eosine Yellowish-(YS) (Eosin)IBA 08/2010
1	Hematoxylin (Haematoxylon)IBA 08/2010

Therapy/Procedure

73	Therapeutics 12/2023 - 02/2002
44	Prostatectomy (Retropubic Prostatectomy) 04/2024 - 02/2002
39	Cryosurgery 12/2023 - 05/2006
24	Radiotherapy 12/2023 - 05/2006
20	Cryotherapy (Therapy, Cold) 12/2023 - 05/2006
9	Nephrectomy 05/2014 - 04/2003
8	Radiofrequency Ablation 10/2011 - 07/2002
5	Brachytherapy 10/2023 - 05/2007
4	Castration 01/2023 - 11/2017
4	Fat-Restricted Diet (Diet, Fat Restricted) 10/2011 - 05/2004
4	Minimally Invasive Surgical Procedures 10/2011 - 02/2007
3	Salvage Therapy 12/2023 - 01/2010
3	Aftercare (After-Treatment) 01/2023 - 09/2010
2	Drug Therapy (Chemotherapy) 03/2019 - 05/2006
2	Operative Surgical Procedures 01/2008 - 04/2007
1	Immunotherapy 12/2023
1	Postoperative Care 09/2021
1	Transurethral Resection of Prostate (TURP) 01/2021
1	Organ Transplantation 01/2019
1	Kidney Transplantation 01/2019
1	Transplantation 01/2019
1	Blood Transfusion (Blood Transfusions) 08/2018
1	Retreatment 04/2015
1	Time-to-Treatment 12/2014
1	Pancreaticoduodenectomy 05/2014
1	Cytoreduction Surgical Procedures 05/2014
1	Segmental Mastectomy (Lumpectomy) 05/2014
1	Neoadjuvant Therapy 09/2013